Human B7-H5 Protein, Mouse IgG2a Fc Tag (Cat. No. B75-H5258) Captured on CM5 chip via anti-mouse antibodies surface can bind Human VSIG3, Fc Tag (Cat. No. VS3-H5258) with an affinity constant of 8.87 μM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
W-0180 | W-0180 | Phase 1 Clinical | France Pierre Fabre Medicament Shanghai Representative Office | Solid tumours | Details |
Onvatilimab | CI-8993; JNJ-61610588 | Phase 1 Clinical | Janssen Global Services Llc, Immunext Inc | Solid tumours; Neoplasms | Details |
HMBD-002 | HMBD-002 | Phase 1 Clinical | Hummingbird Bioscience | Solid tumours; Triple Negative Breast Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
KVA-12123 | KVA-12.1; KVA-12123 | Phase 2 Clinical | Kineta Inc | Pancreatic Neoplasms; Melanoma; Thyroid Neoplasms; Uterine Neoplasms; Lung Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Sarcoma; Prostatic Neoplasms; Head and Neck Neoplasms; Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma; Ovarian Neoplasms; Solid tumours; Kidney Neoplasms | Details |
This web search service is supported by Google Inc.